National Institute of Allergy and Infectious Diseases (NIAID): HIV Infections trials

The registry lists 728 HIV Infections studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 9 are open to participants now and 104 have results posted.

Phase 1 327Phase 2 183Phase 3 57Phase 4 7No phase 195(a study in two phases counts in both)

Studies

Page 6 of 8. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 AdjuvantCompletedNCT00001019Phase 1
• A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related ProblemsCompletedNCT00001015Phase 1
• A Study of AL721 in HIV-Infected Patients With Swollen Lymph NodesCompletedNCT00001012Phase 1
• A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After BirthCompletedNCT00001007Phase 1
• A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph NodesCompletedNCT00001005Phase 1
• A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long TimeCompletedNCT00001002Phase 1
• The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARCCompletedNCT00000999Phase 1
• A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the VirusCompletedNCT00000993Not applicable
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected PatientsCompletedNCT00000991Phase 3
• The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate SymptomsCompletedNCT00000990Phase 2
• A Study of BMY-27857 in Patients With AIDS or AIDS Related ComplexCompletedNCT00000988Phase 1
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV InfectionCompletedNCT00000984Phase 1
• The Safety of Different Dose Levels of Zidovudine in HIV-Infected ChildrenCompletedNCT00000983Phase 2
• A Study of Azidothymidine in HIV-Infected ChildrenCompletedNCT00000982Phase 2
• Comparison of ddI Versus Zidovudine in HIV-Infected PatientsCompletedNCT00000979Phase 2
• Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and ToxicityCompletedNCT00000977Phase 1
• A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii PneumoniaCompletedNCT00000974Phase 1
• A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59CompletedNCT00000972Phase 1
• A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) TherapyCompletedNCT00000969Not applicable
• The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected ChildrenCompletedNCT00000967Phase 1
• The Effects of Zidovudine on the Blood of HIV-Infected PatientsCompletedNCT00000965Not applicable
• The Effect of Stomach Acid on FoscarnetCompletedNCT00000964Phase 1
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take ZidovudineCompletedNCT00000963Phase 2
• The Safety and Effectiveness of BI-RG-587 in HIV-Infected PatientsCompletedNCT00000962Phase 1
• The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected InfantsTerminatedNCT00000961Phase 2
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their InfantsCompletedNCT00000960Phase 3
• Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous InfectionCompletedNCT00000959Not applicable
• A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)CompletedNCT00000958Phase 1
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated SchedulesCompletedNCT00000957Phase 1
• A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160CompletedNCT00000956Phase 1
• Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) InfectionCompletedNCT00000955Not applicable
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and ChildrenCompletedNCT00000952Phase 1
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000948Phase 2
• A Study to Test the Safety of Three Experimental HIV VaccinesCompletedNCT00000946Phase 1
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000944Phase 1
• A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328CompletedNCT00000943Not applicable
• A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their BabiesCompletedNCT00000942Phase 3
• A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your BloodCompletedNCT00000941Phase 1
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIVCompletedNCT00000940Phase 2
• A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as PossibleCompletedNCT00000939Phase 2
• A Study of the Long-Term Outcomes of HIV-Positive PatientsCompletedNCT00000932
• HIV Prevention Counseling for Men Who Have Sex With MenCompletedNCT00000931Phase 3
• A Study of HIV in Newly Infected IndividualsCompletedNCT00000930
• A Study of the Effects of Advantage 24 on the RectumCompletedNCT00000929Phase 1
• Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant CouplesCompletedNCT00000928Phase 1
• A Study of BufferGel in WomenCompletedNCT00000927Phase 1
• A Study of Nonoxynol-9 (N-9) and HIV InfectionCompletedNCT00000926Phase 3
• A Study to Compare Two Different Anti-HIV Drug RegimensCompletedNCT00000924Phase 2
• Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328CompletedNCT00000923Not applicable
• A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)CompletedNCT00000922Not applicable
• Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their NewbornsCompletedNCT00000920Phase 1
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV InfectionCompletedNCT00000919Not applicable
• A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment FailureCompletedNCT00000918Phase 2
• Setting up a Blood Bank for Gene Therapy in HIV-Infected InfantsTerminatedNCT00000917
• A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their BloodCompletedNCT00000916Phase 2
• An HIV Vaccine Preparedness StudyCompletedNCT00000915Not applicable
• A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 WeeksCompletedNCT00000914Not applicable
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive ChildrenCompletedNCT00000913Phase 2
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000912Phase 2
• A Study to Monitor Patients With Primary or Early HIV InfectionCompletedNCT00000911
• A Study to Collect Information About HIV-Positive Pregnant Women and Their BabiesCompletedNCT00000910
• A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV TherapyCompletedNCT00000909Phase 2
• A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive PatientsCompletedNCT00000907
• Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected PatientsCompletedNCT00000906Phase 1
• Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative AdultsCompletedNCT00000904Phase 1
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment RegimenCompletedNCT00000903Phase 3
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior TreatmentCompletedNCT00000902Phase 1
• The Effects of Illnesses on HIV Levels in the BodyCompletedNCT00000900
• A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000899Phase 1
• The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and SaquinavirCompletedNCT00000898Not applicable
• A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and WomenCompletedNCT00000897Not applicable
• A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive PatientsCompletedNCT00000896Not applicable
• A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionCompletedNCT00000895Not applicable
• Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive ChildrenCompletedNCT00000893Phase 1
• A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNCT00000892Not applicable
• Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315CompletedNCT00000891Phase 2
• A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive PatientsCompletedNCT00000890
• A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000889Phase 2
• Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their BabiesCompletedNCT00000888Phase 1
• A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000887Phase 1
• A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)CompletedNCT00000886Phase 1
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320CompletedNCT00000885Phase 2
• A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult VolunteersCompletedNCT00000884Phase 1
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedNCT00000882Phase 2
• A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV DiseaseCompletedNCT00000880Phase 2
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive MothersCompletedNCT00000879Phase 1
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000878Phase 1
• Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedNCT00000877Phase 1
• Safety and Effectiveness of CD4-IgG2 in HIV-Positive ChildrenCompletedNCT00000876Phase 1
• A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GARTCompletedNCT00000874
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected InfantsCompletedNCT00000873Not applicable
• Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV InfectionCompletedNCT00000872Phase 2
• A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult VolunteersCompletedNCT00000871Phase 2
• A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART AloneCompletedNCT00000870Phase 2
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their BabiesCompletedNCT00000869Phase 3
• A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative VolunteersCompletedNCT00000868Phase 1
• The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and ChildrenCompletedNCT00000865Phase 1
• A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected WomenCompletedNCT00000864Phase 1
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected PatientsCompletedNCT00000863Phase 2
• A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant WomenCompletedNCT00000862Phase 1